Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsBiosimilars CLE
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled: "Bio-Similars: The New Litigation Landscape" on Thursday, April 22, 2010 beginning at 2:00 PM (EST). The IPO webinar will provide an overview of the healthcare reform measure that creates a regulatory pathway for generic versions of large-molecule biotech drugs, which bears some resemblance to the longstanding Hatch-Waxman regime that sets out how generic drug companies can challenge patents held by pharmaceutical companies on small-molecule medicines. The webinar will also examine the differences between the two schemes, which are profound and will prove to be of great importance in...Full post as published by Patent Docs on April 10, 2010 (boomark / email).
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Red or Blue: Well Likely to See Biosimilars Either Way
Administrations First Volley on Biosimilars: 7 Years of Exclusivity is Long Enough
New Pathway for Biosimilars Introduced
Patent Litigation Under a Future Biosimilars Act
Senate Committee: 12 Years of Data Exclusivity is Cool







